20 Years
In Express Pharma’s 20th year, we present the second installment of thought leaders predicting changes to watch out for in the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
‘The health industry as a whole has a positive future’
In a free-wheeling conversation with Viveka Roychowdhury, Patrick Figgis, Global Health Leader, PwC and Sujay Shetty,…
Issues and trends in the Indian pharma industry
There is a dire need for carefully balancing the requirements of the public and the industry, opine Bhavik Narsana, Partner,…
Recent surge in pharma patent litigation
The next decade or so in the pharmaceutical patent space in India will be interesting to watch out for. As more product patents…
The good, the bad and the ugly in Indian pharma
Chirag Talati, Analyst, Kotak Institutional Equities (KIE), gives an insight on the recent global currency movements and the risks…
Towards Holistic Healing
Express Pharma goes beyond allopathy in this special section, which looks at how age old remedies like ayurveda are being…
Potential of regenerative medicine
Application of stem cell-based therapies will be the turning point in the treatment of hitherto inadequately treated or incurable…
Ayurveda – A potential global medical system
The Government of India has recently drafted a national policy on traditional systems practiced in India. Shashank Sandu,…
Integrative medicine: An idea whose time has come
As the benefits of integrating ayurveda and allopathy, especially in the treatment of lifestyle diseases and post operative care…
The ‘Counterfeit’ conundrum in pharma industry – Is it time for concerted action?
The quality control measures at the customs with regard to the import and the export of medicines and APIs need to be strengthened…
Recent cardiovascular clinical trials framing debate on personalised treatment: GlobalData
It has been proposed that one should err on the side of short-term therapy for patients at high risk of bleeding
Clinical Research
What does the next 20 years hold for clinical research in India? Express Pharma presents some perspectives and sugestions for…
Clinical research in India: Where do we go from here?
A policy promoting clinical research and innovation needs to be supported by action at various levels opines Suneela Thatte,…
Bring research back on the agenda
The country has a responsibility towards the health of its citizens that translates to creating an enabling environment, advocates…
CT regulation in India: Science or social justice?
Mark Barnes, JD, LLM Faculty Co-Director, Multi-Regional Clinical Trials Center at Harvard (Harvard MRCT), Lecturer, Harvard Law…
Lack of suitable resources limiting Ebola diagnoses in West Africa: GlobalData
Poor logistics is a more difficult problem to solve, as the reagents used for testing require constant refrigeration during their…
Competition issues in the Indian pharma sector
The Competition Commission of India has undertaken capacity building exercises and have received specialised training in relation…
Zooming drug prices in US
A molotov cocktail of higher demand and lowered supply is believed to have caused an explosion in generic drug prices in the US,…
Re-Building Indian Pharma Inc
PM Modi's 'Make in India' campaign highlights pharma as one of the key sectors for growth but it is essential to first rebuild…
‘IRHT would focus on Africa, Japan and Latin America as potential markets of the future’
India Brand Equity Foundation has been at the forefront of positioning Brand India Pharma and has taken up the mantle to further…